Director, Field Market Access

The role

The Director, Field Market Access will serve as the primary field market access leader within a defined geographic region. This person will execute market access strategies focused on payer engagement, reimbursement, contracting, affordability, and patient access.

What you will do

• Negotiate directly with Commercial and Government Payers to ensure pricing and coverage.
• Execute Market Access Strategies with Payers and Treatment Centers.
• Educate providers on local payer trends, billing and coding for gene therapy.
• Support offices for individual patient reimbursement journeys and troubleshooting.
• Monitor, analyze, and influence local payer trends in rare disease and gene therapy.
• Provide training and education programs on reimbursement and health policy to internal and external stakeholders.
• Work with cross functional field pod to support access and coverage.
• Develop local and regional relationships with professional societies, medical associations, advocacy groups, thought leaders and trade groups.

Required qualifications

• BS required
• 12+ years of progressive experience in the pharmaceutical or biotech industry
• 5+ years in market access, including field roles
• Hospital and payer experience establishing coverage policies for complex therapies
• Demonstrated success in building and managing relationships with payers and financial decision-makers in Treatment Centers
• Established relationships with Commercial payers
• Buy & bill experience
• Experience working in local, cross-functional field teams
• Excellent communication, presentation, and negotiation skills
• Proficiency with CRM systems, PowerPoint, and Excel
• Willingness to travel approximately 50% of the time/as needed

Nice to have

• advanced degree
• Medicaid relationships
• Experience in cell or gene therapy

About the company

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. The company uses base editing technology to advance a diversified portfolio of base editing programs.